Regimen chemotherapy and autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells T-Lymphocytes Bone Marrow Cells Neural Stem Cells Cells, Cultured Induced Pluripotent Stem Cells Antilymphocyte Serum Multipotent Stem Cells Fetal Stem Cells Fetal Blood Neoplastic Stem Cells Spermatogonia Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases54

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Lymphoma, B-Cell Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Neoplasms, Second Primary Leukemia, Plasma Cell Neoplasm Recurrence, Local Leukemia, Myeloid Neutropenia Leukemia Acute Disease Neoplasms Disease Progression Breast Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Hematologic Diseases Hepatic Veno-Occlusive Disease Lymphoma, AIDS-Related Neuroblastoma Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Mucositis Cytomegalovirus Infections Anemia, Aplastic Infection Medulloblastoma Thrombocytopenia Severe Combined Immunodeficiency Central Nervous System Neoplasms Opportunistic Infections Lymphoproliferative Disorders Chromosome Aberrations Leukemia, Lymphocytic, Chronic, B-Cell Disease Models, Animal Postoperative Complications Paraproteinemias Blood Group Incompatibility Lung Neoplasms Bone Neoplasms Mycoses Chronic Disease

Chemicals and Drugs50

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Cytarabine Carmustine Thiotepa Vincristine Doxorubicin Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Antigens, CD34 Ifosfamide Thalidomide Antineoplastic Agents Granulocyte Colony-Stimulating Factor Prednisone Podophyllotoxin Mitoxantrone Idarubicin Cisplatin Carboplatin Immunosuppressive Agents Antibodies, Monoclonal Keratins, Type II Immunoglobulin Light Chains Vidarabine Bleomycin HLA Antigens Methotrexate Antilymphocyte Serum Immunoconjugates Stem Cell Factor Recombinant Proteins Cyclosporine Prednisolone Minor Histocompatibility Antigens Antigens, CD Antigens, CD20 Immunologic Factors Tacrolimus Nitrogen Mustard Compounds Biological Markers Antibodies, Neoplasm Myeloma Proteins Vinblastine

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Disease-Free Survival Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Prospective Studies Drug Administration Schedule Blood Component Removal Chemotherapy, Adjuvant Histocompatibility Testing Feasibility Studies Fatal Outcome Life Tables Radioimmunotherapy Risk Factors Neoplasm Staging Heart Transplantation Immunotherapy Clinical Trials as Topic Lung Transplantation Kaplan-Meier Estimate Blood Transfusion, Autologous Organ Transplantation Treatment Failure Transplantation, Isogeneic Lymphocyte Transfusion Flow Cytometry Pilot Projects Immunosuppression Transplantation Islets of Langerhans Transplantation Positron-Emission Tomography Lymphocyte Depletion Randomized Controlled Trials as Topic Predictive Value of Tests Cell Separation Immunophenotyping Platelet Count Pancreas Transplantation Multivariate Analysis Transplantation, Heterologous Proportional Hazards Models Severity of Illness Index Radiotherapy Donor Selection Cell Culture Techniques Immunomagnetic Separation Leukocyte Count Stem Cell Research Drug Therapy Cohort Studies Infusions, Intravenous Cell- and Tissue-Based Therapy Disease Models, Animal Fetal Tissue Transplantation Actuarial Analysis Colony-Forming Units Assay Transplantation, Heterotopic Neoadjuvant Therapy Immunohistochemistry Incidence Blood Cell Count Immunotherapy, Adoptive Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Lymphocyte Count Platelet Transfusion Heart-Lung Transplantation Cell Count

Psychiatry and Psychology1

Phenomena and Processes27

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Dose-Response Relationship, Drug Transplantation Immunology Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Cell Lineage Cell Proliferation Platelet Count Drug Resistance, Neoplasm Regeneration Immunocompromised Host Transplantation Tolerance Leukocyte Count Chromosome Aberrations Virus Activation Cell Survival Blood Cell Count Lymphocyte Count Cell Count Phenotype

Disciplines and Occupations2

Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Clinical Trials as Topic Kaplan-Meier Estimate Treatment Failure Pilot Projects Randomized Controlled Trials as Topic Predictive Value of Tests Age Factors Multivariate Analysis Proportional Hazards Models Severity of Illness Index Donor Selection Cohort Studies Actuarial Analysis Incidence Tissue and Organ Procurement

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Stem Cells Disease-Free Survival Etoposide Cyclophosphamide Hodgkin Disease Lymphoma, Non-Hodgkin Myeloablative Agonists Cytarabine Recurrence Carmustine Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Graft vs Host Disease Thiotepa Vincristine Bone Marrow Purging Survival Analysis Hematologic Neoplasms Whole-Body Irradiation Lymphoma, Mantle-Cell Amyloidosis Retrospective Studies Doxorubicin Busulfan Hematopoietic Stem Cells Boronic Acids Dexamethasone Prognosis Pyrazines Graft Survival Antibodies, Monoclonal, Murine-Derived Follow-Up Studies Antineoplastic Agents, Alkylating Lymphoma, Follicular Antigens, CD34 Autografts Lymphoma, T-Cell, Peripheral Liver Transplantation Ifosfamide Thalidomide Antineoplastic Agents Induction Chemotherapy Time Factors Mesenchymal Stem Cell Transplantation Granulocyte Colony-Stimulating Factor Prednisone Leukapheresis Lymphoma Podophyllotoxin Lymphoma, Large B-Cell, Diffuse Transplantation Chimera Neoplasm, Residual Maintenance Chemotherapy Tissue Donors Leukemia, Myeloid, Acute Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Lymphoma, B-Cell Mitoxantrone Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Embryonic Stem Cells Idarubicin Cisplatin Neoplasms, Second Primary Leukemia, Plasma Cell Infusions, Spinal Carboplatin Prospective Studies Drug Administration Schedule Immunosuppressive Agents Adult Stem Cells Blood Component Removal Chemotherapy, Adjuvant Neoplasm Recurrence, Local Histocompatibility Testing Antibodies, Monoclonal Feasibility Studies Leukemia, Myeloid Fatal Outcome Neutropenia Cell Differentiation Keratins, Type II Life Tables Histocompatibility

No FAQ available that match "regimen chemotherapy and autologous stem cell transplantation"